EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A trophoblast glycoprotein specific 5T4-Vδ2 bispecific T cell engager recruits Vγ9Vδ2-T cells for tumor-selective cytotoxicity across solid malignancies

Milon de Jong, Rok Žiberna, Myrthe Veth, Elisabetta Michielon, Julia Myrda, Jens Seidel, Maryam Akbarzadeh, Pauline M van Helden, André N Vis, Sarah Derks, Roeland Lameris, Tanja D de Gruijl und 1 weitere

Clinical Immunology · 2026-06 · 285 · 110707

DOI: 10.1016/j.clim.2026.110707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Immunology, 2026-06. Verfasst von Milon de Jong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and …. Hauptthemen laut MEDLINE: Receptors, Antigen, T-Cell, gamma-delta, T-Lymphocytes, Antibodies, Bispecific, Neoplasms. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LAVA Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Antigen, T-Cell, gamma-deltaT-LymphocytesAntibodies, BispecificNeoplasmsHumansAnimalsMiceCell Line, TumorCytotoxicity, ImmunologicFemaleMembrane Glycoproteins

Stichwörter der Autor:innen

5T4 antigenBispecific T cell engagersSingle-domain antibodySolid malignanciesVγ9Vδ2-T cells

Substanzen

Receptors, Antigen, T-Cell, gamma-deltatrophoblastic glycoprotein 5T4, humanAntibodies, BispecificMembrane Glycoproteins

Autor:innen und Institutionen

  • Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands; Amsterdam institute for Infect…
  • Lava Therapeutics, Utrecht, the Netherlands.
  • Department of Urology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands; Oncode Institute, Amsterdam, t…
  • Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.
  • Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands; Lava Therapeutics, Utrecht, th…

Förderung

  • LAVA Therapeutics

Zitieren

APA

de Jong, M., Žiberna, R., Veth, M., Michielon, E., Myrda, J., Seidel, J., Akbarzadeh, M., van Helden, P. M., Vis, A. N., Derks, S., Lameris, R., de Gruijl, T. D., & van der Vliet, H. J. (2026). A trophoblast glycoprotein specific 5T4-Vδ2 bispecific T cell engager recruits Vγ9Vδ2-T cells for tumor-selective cytotoxicity across solid malignancies. Clinical Immunology, 285, 110707. https://doi.org/10.1016/j.clim.2026.110707

Vancouver

de Jong M, Žiberna R, Veth M, Michielon E, Myrda J, Seidel J, et al. A trophoblast glycoprotein specific 5T4-Vδ2 bispecific T cell engager recruits Vγ9Vδ2-T cells for tumor-selective cytotoxicity across solid malignancies. Clinical Immunology. 2026;285:110707. doi:10.1016/j.clim.2026.110707

BibTeX
@article{deJong2026,
  author = {de Jong, Milon and Žiberna, Rok and Veth, Myrthe and Michielon, Elisabetta and Myrda, Julia and Seidel, Jens and Akbarzadeh, Maryam and van Helden, Pauline M and Vis, André N and Derks, Sarah and Lameris, Roeland and de Gruijl, Tanja D and van der Vliet, Hans J},
  title = {A trophoblast glycoprotein specific 5T4-Vδ2 bispecific T cell engager recruits Vγ9Vδ2-T cells for tumor-selective cytotoxicity across solid malignancies},
  journal = {Clinical Immunology},
  year = {2026},
  volume = {285},
  pages = {110707},
  doi = {10.1016/j.clim.2026.110707}
}
Kostenlos starten →